SINCO PHARMA released its annual performance, with a profit attributable to shareholders of HKD 42.045 million, a year-on-year decrease of 0.7%
I'm PortAI, I can summarize articles.
SINCO PHARMA released its annual results for the year ending December 31, 2024, with revenue of 2.821 billion yuan, a year-on-year increase of 11.07%. The profit attributable to shareholders was 42.045 million yuan, a year-on-year decrease of 0.7%. Earnings per share were 0.02 yuan, and a final dividend of 0.20 Hong Kong cents is proposed. Gross profit decreased to 299.9 million yuan, with a gross profit margin falling to 10.6%, mainly due to increased procurement costs caused by the depreciation of the US dollar
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments